Levetiracetam Injection
Product Images NDC 65145-173

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 65145-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levetiracetam-1000mg-100ml-10mg-ml-alu-pouch-label (Levetiracetam 1000mg 100ml 10mg mL Alu Pouch Label)

Label for Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg/100 mL (10 mg/mL) intravenous infusion. The single-dose injection comes in a 100 mL dual port bag with aluminum overwrap. It is manufactured by Caplin Steriles Limited and distributed by Caplin Steriles USA Inc. The label includes usage instructions, storage recommendations, and a barcode.*

FDA Label Image

Levetiracetam-1000mg-100ml-10mg-ml-bag-label (Levetiracetam 1000mg 100ml 10mg mL Bag Label)

Levetiracetam in 0.75% Sodium Chloride Injection 1000 mg/100 mL (10 mg/mL) intravenous injection label. The label states this is a single-dose 100 mL dual port bag for infusion over 15 minutes. It is manufactured by Caplin Steriles Limited and distributed by Caplin Steriles USA Inc. The label includes storage instructions, a barcode, and cautions about use and packaging.*

FDA Label Image

Levetiracetam-1500mg-100ml-15mg-ml-alu-pouch-label (Levetiracetam 1500mg 100ml 15mg mL Alu Pouch Label)

Levetiracetam in 0.54% Sodium Chloride Injection 1500 mg/100 mL intravenous injection label from Caplin Steriles Limited. The label includes instructions for infusion, storage recommendations, cautions, and distributor information for Caplin Steriles USA Inc. It is a single-dose 100 mL pouch.*

FDA Label Image

Levetiracetam-1500mg-100ml-15mg-ml-bag-label (Levetiracetam 1500mg 100ml 15mg mL Bag Label)

Levetiracetam 1500 mg/100 mL (15 mg/mL) injection label in 0.54% Sodium Chloride for intravenous infusion, 100 mL vial. The label specifies infusion instructions, storage conditions (20° to 25°C), and cautions against using plastic containers in series. Manufactured by Caplin Steriles Limited and distributed by Caplin Steriles USA Inc. Includes barcode and batch coding area.*

FDA Label Image

Levetiracetam-500mg-100ml-5mg-ml-alu-pouch-label (Levetiracetam 500mg 100ml 5mg mL Alu Pouch Label)

Label for Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL (5 mg/mL) for intravenous infusion. The single-dose 100 mL bag is labeled for infusion over 15 minutes and includes storage instructions. Distributed by Caplin Steriles USA Inc., Hamilton, NJ, made in India. NDC 65145-173-01.*

FDA Label Image

Levetiracetam-500mg-100ml-5mg-ml-bag-label (Levetiracetam 500mg 100ml 5mg mL Bag Label)

Label for Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL (5 mg/mL) intravenous injection. The single-dose dual port bag is labeled for infusion over 15 minutes, with storage and usage instructions, manufactured by Caplin Steriles Limited, distributed by Caplin Steriles USA Inc.*

FDA Label Image

Levetiracetam-caplin-logo (Levetiracetam Caplin Logo)

FDA Label Image

Figure-1 (Levetiracetam Figure 1)

A bar chart depicting the percentage of patients for three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). Each bar is labeled with the number of patients (N) and indicates statistical significance versus placebo for the Levetiracetam groups.*

FDA Label Image

Figure-2 (Levetiracetam Figure 2)

A bar chart showing the percentage of patients across three groups: Placebo (N=111) at 6.3%, Levetiracetam 1000 mg/day (N=106) at 20.8%, and Levetiracetam 2000 mg/day (N=105) at 35.2%. Asterisks indicate statistically significant differences compared to placebo.*

FDA Label Image

Figure-3 (Levetiracetam Figure 3)

A bar chart comparing the percentage of patients between placebo and Levetiracetam 3000 mg/day groups. The placebo group (N=104) shows 14.4% of patients, while the Levetiracetam group (N=180) shows 39.4%, with a note indicating statistical significance versus placebo.*

FDA Label Image

Figure-4 (Levetiracetam Figure 4)

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=84) shows 45.2%, and the Levetiracetam group (N=79) shows 72.2%, with a notation indicating statistical significance versus placebo.*

FDA Label Image

Str (Levetiracetam Structure)

Chemical structure of Levetiracetam. The diagram shows the molecular arrangement including a pyrrolidone ring and attached functional groups, depicting the molecular structure of the active ingredient in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.